21 CFR 211.192 Batch Release · Pre-Inspection Review ComplianceWorxs · 2026
Run this checklist against your batch release files before inspection. Each section maps to the specific question an FDA investigator will ask. If the answer to any investigator question is "I don't know" or "it's not in the file," that is your exposure.
01 For every batch released in the review period
Investigator's question

"Who released this batch — and what is the record of that authorization decision?"

  • The authorizing individual is identified by name and title — not just a signature or initials
  • The date and time of authorization is documented and can be verified as occurring before release to distribution
  • The authorizing individual's qualification to make the release determination is established in the record (role, training, SOP authority)
  • The release decision is traceable to the specific batch number and lot being released — not a blanket approval
02 For batches containing exceptions or out-of-trend results
Investigator's question

"What specific evidence did the authorizing individual review when making the release decision for this exception — and where is that documented?"

  • A document exists — separate from the batch record signature — that captures what the reviewer actually reviewed in evaluating the exception
  • The specific atypical or out-of-trend result is identified and the decision about that specific result is documented
  • The historical process data or specification context that makes the result atypical is referenced in the record
  • The regulatory standard governing the release decision is cited (not just the specification — the decision standard)
  • Alternative conclusions considered (e.g., reject, investigate further) are documented along with the reason they were not selected
03 For the release decision itself
Investigator's question

"What was the basis for concluding this batch met all release criteria — specifically, what did the authorizing individual evaluate to reach that conclusion?"

  • The release rationale is documented as a decision — not as a checkbox or signature on a form that confirms review occurred
  • All required testing is confirmed complete prior to the release authorization date — or, if pending, the basis for releasing before completion is documented
  • Any open deviations or investigations related to the batch are referenced and their status (closed, ongoing) is documented in the release record
  • The release authorization record can be produced in under five minutes — not reconstructed from multiple systems
04 System and procedural review
Investigator's question

"Does your written procedure require this type of authorization documentation — and is your practice consistent with the procedure?"

  • Your batch release SOP explicitly requires a separate authorization record (not just a batch record review) for batches containing exceptions
  • The SOP defines what the authorization record must contain — not just that one is required
  • A sample of recent exception batches has been reviewed against this checklist — not just the batches most likely to be reviewed during inspection
  • The QA team can explain, in two sentences, the difference between a batch record review signature and a batch release authorization record
The single most common gap

The signature exists. The authorization record does not.

In the majority of batch release 483 observations, the QP signature is present on the batch record. The observation is not about the absence of review — it is about the absence of a record that captures what was reviewed, what standard was applied, and what the authorizing individual concluded. A batch record signature proves review occurred. It does not constitute an authorization record for the release decision.

The Batch Release Authorization case file produces a complete authorization record for any batch release decision — structured, 5-element, producible in minutes at the time of decision.

Get the Case File — $149 →